About Apogee Therapeutics, Inc. Common Stock
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Market Cap
$2.33B
Employees
196
Listed Since
July 14, 2023
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Website
www.apogeetherapeutics.comPhone
650-394-5230
Headquarters
221 CRESCENT ST.
WALTHAM, MA 02453
CIK
0001974640